Matching Biomarkers to Disease Biology & Therapy
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
Dr. Sicklick will discuss the importance of biomarker testing and research that correlates the biology of GIST with treatment.
In this interview with researcher & surgical oncologist Dr. Jason Sicklick shares about his passion for SDH-deficient GIST research.
Our most recent GIST Days of Learning (GDOLs) were in-person again! Deputy Director, Laura Occhiuzzi and Senior Director of Outreach & Engagement Diana Nieves traveled to San Diego and Miami to meet with GIST experts and members of our community.
UC San Diego Health released a post today titled, "Genetic Testing Cost Effective for Newly Diagnosed GIST" discussing a new paper published in JAMA Network Open by Moores Cancer Center's Dr. Jason Sicklick and colleagues which covered genetic testing for GIST patients.
The Life Raft Group and UCSD hosted a three-day event at University of California, San Diego UCSD-Moores Cancer Center from July 13th through July 15th. A GIST Awareness Day (GAD) event took place on July [...]
PICTURED: Dr. Jason Sicklick, Deb Melikian,Norman Scherzer, & Malcolm Aste Record numbers attended our GIST Day of Learning on July 15th in La Jolla, California. Over 100 people gathered to [...]
It's not too late to sign up for the GIST Day of Learning (GDOL) in La Jolla/San Diego on July 15th. We are very excited to have some of the top GIST experts present [...]
On July 13th, the Life Raft Group will be celebrating the third annual GIST Awareness Day! Every year, our goal is to increase awareness about GIST worldwide. This year, we are celebrating GAD with our [...]
Jason Sicklick, M.D Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, M.D., indicate that small [...]
New York, NY and Wayne, NJ - January 12, 2017 Columbia University Medical Center, NewYork-Presbyterian and the Life Raft Group (LRG), a patient advocacy organization specializing in GIST cancer, announced today that they have [...]